Peng Sun

机构：Biogen (United States), Boehringer Ingelheim (Germany), Sun Yat-sen University, Xuan Wu Hospital of the Capital Medical University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Zhejiang University, Nanjing Medical University · ORCID：0000-0002-6589-6827

发表论文 85 篇 · 总被引 1093 次 · h-index 17

代表论文

• Quantitative stress and damage mapping in multiple network elastomers using a single mechanophore (2025 · Nature Communications · 被引 4)
• Systematic Analysis of Factors Affecting Human Epidermal Growth Factor Receptor 2 Interpretation Consistency: Staining Protocols, Artificial Intelligence–Based Image Standardization, and Classification Criteria (2025 · Laboratory Investigation · 被引 3)
• Prognostic value of tumor-infiltrating lymphocytes (TILs) in Luminal breast cancer: A novel computational method for assessing TILs abundance and spatial distribution patterns (2025 · The Breast · 被引 2)
• Preliminary results from the dose-escalation stage of a phase I trial of an anti-CCR8 antibody in patients with relapsed/refractory cutaneous T-cell lymphoma (R/R CTCL). (2025 · Journal of Clinical Oncology · 被引 2)
• Puncture of Mechanochromic Tough Elastomeric Membranes (2025 · Acta Mechanica Solida Sinica · 被引 1)
• HER2-positive breast cancer with invasive micropapillary carcinoma component shows immunosuppressive microenvironment and resistance to neoadjuvant therapy (2025 · Frontiers in Immunology · 被引 1)